lde-225
Showing 1 - 1 of 1
Resectable Pancreatic Cancer Trial in New Brunswick (LDE-225)
Withdrawn
- Resectable Pancreatic Cancer
- LDE-225
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Dec 10, 2014